These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Positron emission tomography in dementia. Santens P; Petit H Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592 [TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of neurotransmission and brain receptors in dementia. Pappatà S; Salvatore E; Postiglione A J Neuroimaging; 2008 Apr; 18(2):111-24. PubMed ID: 18380693 [TBL] [Abstract][Full Text] [Related]
4. [Usefulness of positron-emission tomography in the study of the central nervous system]. Arquè Bertrán JM; Frost JJ Med Clin (Barc); 1990 Apr; 94(16):633-6. PubMed ID: 1974314 [No Abstract] [Full Text] [Related]
5. [Positron emission tomography (PET) in the study of senile dementia]. Terashi A Rinsho Shinkeigaku; 1986 Dec; 26(12):1302-5. PubMed ID: 3493871 [No Abstract] [Full Text] [Related]
7. [Cerebral circulation and metabolism in elderly patients with dementia]. Sawada T No To Shinkei; 1987 Jan; 39(1):35-47. PubMed ID: 3548777 [No Abstract] [Full Text] [Related]
8. Drug development for neurodegenerative diseases: role of PET. Rinne JO Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860 [TBL] [Abstract][Full Text] [Related]
9. [Imaging brain function with autoradiography and positron emission tomography]. Kato M; Hosokawa S; Kuwabara Y Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1182-91. PubMed ID: 1972583 [No Abstract] [Full Text] [Related]
10. PET: its clinical role in neurology. Brooks D J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):1-5. PubMed ID: 1672706 [No Abstract] [Full Text] [Related]
11. [Clinical indications for PET of the central nervous system: primary brain tumors, vascular and degenerative dementia]. Bicik I; von Schulthess GK Schweiz Rundsch Med Prax; 1993 Aug; 82(34):905-9. PubMed ID: 8372294 [TBL] [Abstract][Full Text] [Related]
12. Neurotransmitters are important, but so is metabolism. Commentary on "The current status of PET scanning with respect to schizophrenia". Gur RE; Gur RC Neuropsychopharmacology; 1992 Aug; 7(1):63-5; discussion 73-5. PubMed ID: 1355969 [No Abstract] [Full Text] [Related]
13. Positron emission tomography. Biomedical research and clinical application. Wolf AP; Fowler JS Neuroimaging Clin N Am; 1995 Feb; 5(1):87-101. PubMed ID: 7743087 [TBL] [Abstract][Full Text] [Related]
16. [F-18 FDG PET in dementia]. Ichiya Y Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095 [TBL] [Abstract][Full Text] [Related]
17. Commentary on "The current status of PET scanning with respect to schizophrenia". Buchsbaum MS Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970 [No Abstract] [Full Text] [Related]
18. [Pathophysiology of dementia and medical imaging]. Yonekura Y Rinsho Hoshasen; 1989 Oct; 34(11):1349-53. PubMed ID: 2601097 [TBL] [Abstract][Full Text] [Related]
19. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease. Baron JC; Frackowiak RS; Herholz K; Jones T; Lammertsma AA; Mazoyer B; Wienhard K J Cereb Blood Flow Metab; 1989 Dec; 9(6):723-42. PubMed ID: 2684991 [No Abstract] [Full Text] [Related]
20. Positron emission tomography in aging and dementia: effect of cerebral atrophy. Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]